2. Case Presentation
A 34-year-old woman from Maharashtra, India presented with right breast swelling, generalized malaise, and decreased appetite. She gave prior history of bilateral breast abscesses three months back, for which she underwent incision and drainage at another facility. Histopathology reports had demonstrated acute on chronic granulomatous mastitis with the presence of Langhans’ type of giant cells with acid-fast bacilli seen on Ziehl–Neelson staining. She was started on a course of anti-tubercular drugs at the previous facility. The patient denied any history of previous trauma to the breast or diabetes mellitus. She reported no history of breastfeeding during the period when she developed the abscess.
At presentation, she reported a swelling on her right breast associated with throbbing pain and low-grade fever. The left breast showed a healthy scar of previous surgery. Vital parameters were unremarkable and local examination demonstrated a tender swelling over the right breast in the upper and outer aspect. It was about 10 cm × 7 cm in size and associated with local warmth, induration, and fluctuation. Blood tests revealed a leucocyte count of 18,000/mm3
with neutrophilia. A diagnosis of recurrent breast abscess was made. She underwent incision and drainage of the breast under general anaesthesia. Intra-operatively an indurated mass with multiple small abscesses containing greyish green pus was seen (Figure 1
A,B). About 150 cc of pus was evacuated and all necrotic tissue was debrided. This pus cavity was in continuity with previously drained abscess. Post operatively she was started on a course of intravenous third generation cephalosporin. Pus was sent for Gram staining, Ziehl–Neelson (ZN) staining and culture. Gram staining was negative for bacteria, but primary ZN staining demonstrated acid-fast bacilli in fair number, suggestive of mycobacterial infection. Histopathology report was suggestive of periductal and perilobular inflammation comprising lymphocytes, plasma cells, polymorphs, foamy macrophages, histiocytes, and occasional Langhans’ type of giant cells, along with areas of micro-abscesses and frank oedema. Further, cystic spaces surrounded by neutrophilic aggregates were noted corresponding to CNGM. No micro-calcifications or granulomas were reported (Figure 2
). As per hospital protocol Cartridge-based Nucleic Acid Amplification Test for Mycobacterium tuberculosis
) was ordered to rule out tuberculosis. The test was negative.
Aerobic culture obtained after two weeks revealed rapidly growing non-tuberculous mycobacteria. Line probe speciation further demonstrated Mycobacterium abscessus
as the causative organism. Based on histological and microbiological reporting, diagnosis of cystic neutrophilic granulomatous mastitis secondary to Mycobacterium abscessus
was made. Patient by this time had developed a new abscess at 12 o’ clock. Previous two incision sites at 10 and 3 o’ clock positions were noted to be actively draining greenish pus (Figure 1
C). On incision and drainage, all three sites were noted to be communicating with each other. The necrotic breast tissue was aggressively debrided extending up to pectoralis fascia in the superior outer aspect, following which the patient was advised regular dressing changes. Anti-tubercular therapy was stopped. Based on American Thoracic Society/Infectious Diseases Society of America guidelines and antibiotic sensitivity report, combination antimicrobial therapy involving Clarithromycin and Amikacin for two weeks was given, followed by Clarithromycin monotherapy for two months. Follow up of six months has shown her to be disease and symptom free.
CNGM is a rare disease of breast seen in around 1% of all breast specimens. It is a distinct type of granulomatous mastitis with a peculiar histopathological pattern. There is however a lack of consensus over the definition of the disease with CNGM often used interchangeably with Idiopathic Granulomatous Mastitis (IGM) and Granulomatous Lobular Mastitis (GLM). Wu et al. [3
] suggested the use of ‘Cystic Neutrophilic Granulomatous Mastitis’ over IGM and GLM and proposed to recognise CNGM as a distinct entity. The characteristic feature of the disease is the presence of lobulo-centric granulomatous mastitis with cystic spaces rimmed by neutrophils and occasionally containing Gram-positive bacilli.
is rapidly emerging nontuberculous mycobacterium that is notorious for being resistant to standard anti-microbial therapies, thus posing therapeutic challenges. Literature review showed sixteen cases of M. abscessus
associated with infectious mastitis, demonstrated women ranging 20–54 years (Table 1
]. However only two cases of CNGM were associated with Mycobacterium abscessus.
Typically seen in parous women of childbearing age, the disease mimics several more common conditions. CNGM presents as a breast mass with nipple inversion. Breast pain, sinus formation and abscesses may also be seen. The disease is usually unilateral. However, 8.5% patients present with bilateral disease. In the present case though, the patient had a past history of surgery for bilateral breast abscesses. However, recurrent breast abscess was seen only in the right breast.
First noted as a distinct histopathological picture of CNGM in 2002, Taylor et al. were able to identify Corynebacterium species in a cohort of 34 patients with cystic lipid filled spaces surrounded by neutrophilic aggregates [19
]. Corynebacterium kroppenstedtii
was the most common isolate. However, the exact pathogenic role of coryneforms in CNGM is unknown. The present case showed acid-fast bacilli on primary smear, however a Cartridge-based Nucleic Acid Amplification Test (GeneXpert®
) ruled out tuberculosis of the breast, which is endemic to the region. Bacterial culture revealed rapidly growing NTM which was M. abscessus
Postulated aetiologies in soft tissue infections by M. abscessus
include direct contamination by material or water in traumatic injuries or surgical wound or colonization and dissemination in immunocompromised patients. It is known to cause infection of the breast tissue in immunocompromised patients (or patients who have undergone reconstructive breast surgery [5
]. However, in this case there was no such history).
Ultrasonography of the disease is rarely reported in literature with the most common findings being mass, dilated ducts, oedema, and abscesses [3
]. Most of these findings are assigned a Breast Imaging and Reporting Data System (BIRADS) score of 4 (suspicious of malignancy). CNGM, therefore presents many diagnostic and therapeutic challenges as it mimics invasive carcinoma [1
]. Sonography in present case showed breast abscess with necrotic tissue. Histopathologic analysis combined with bacterial culture led to the diagnosis of CNGM secondary to non-tuberculous mycobacterium. However, carcinoma of the breast and tuberculosis must be ruled out before mainstay therapy is undertaken.
Two prominent subspecies, M. abscessus
and M. abscessus
subsp. massiliense, have been known to encode different erm-41 gene patterns, which encodes for macrolide resistance. This poses obvious challenges as the recommended guidelines suggest Clarithromycin as the gold standard of monotherapy combined with Amikacin or Cefoxitin. Resistance rates of Clarithromycin ranges up to 20%, while Cefoxitin and Amikacin yield around 10% and 10% respectively [20
]. In the present case, initially drainage of abscess and debridement of necrotic tissue was done. This was followed by intravenous amikacin for 14 days and oral Clarithromycin tablets for 10 weeks. A recurrence of mastitis is another issue associated with M. abscessus
. Hence, these patients require prolonged antibiotic therapy and regular follow up.
CNGM due to non-tuberculous mycobacteria is a rare entity. It is usually seen in immunocompromised individuals or those who undergo breast reconstruction. Sometimes, no obvious predisposing factors can be found.
In regions where tuberculosis is endemic, granulomatous inflammation of the breast is usually assumed to be tubercular in origin. It is imperative that bacterial cultures and speciation are done to rule out non-tubercular mycobacterial infection to make sure the patient does not receive inadequate or potentially harmful therapies.